Related Experiment Video

Updated: May 18, 2026

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
08:36

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

Breast cancer and metastasis: on the way toward individualized therapy

Adriana Priscila Trapé1, Ana Maria Gonzalez-Angulo

  • 1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, U.S.A.

Cancer Genomics & Proteomics
|September 20, 2012
PubMed

Insights

Breast cancer (BC) relapse is common due to drug resistance. Systems biology integrating multi-omics data can reveal metastatic mechanisms and identify new therapeutic targets for personalized care.

Area of Science:

  • Oncology
  • Genomics
  • Proteomics
  • Systems Biology

Background:

  • Breast cancer (BC) is the most common cancer in women.
  • Advanced BC treatments improve survival but drug resistance leads to frequent relapse.
  • Understanding metastatic mechanisms is crucial for effective treatment.

Purpose of the Study:

  • To review findings on genomic, transcriptomic, and proteomic analyses in metastatic breast cancer.
  • To highlight the role of systems biology in interpreting multi-omics data.
  • To emphasize the need for clinical trials focused on metastasis prevention.

Main Methods:

  • Review of published literature on multi-omics studies in breast cancer metastasis.
  • Integration of genomic, transcriptomic, and proteomic data interpretation.
  • Application of systems biology principles to understand metastatic processes.

Main Results:

  • Multi-omics data reveal complex mechanisms driving breast cancer metastasis and drug resistance.
  • Systems biology provides a framework to integrate diverse molecular data.
  • Identification of potential therapeutic targets for overcoming resistance and preventing metastasis.

Conclusions:

  • Systems biology approaches are essential for deciphering complex metastatic mechanisms in breast cancer.
  • Targeting identified aberrations can lead to novel therapeutic strategies.
  • Re-designing clinical trials for metastasis prevention is key to improving personalized care and patient outcomes.

More Related Videos

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...